Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.15 | ||
| Price to Tang. Book | 1.82 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -50.68% | ||
| Return on Equity | -101.94% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
EthTry PLC, formerly Igraine plc, is a United Kingdom-based investing company focused on the development of battery energy storage and life sciences sectors. The Company’s commercial objective is to seek investment opportunities that are at inflection points that, if proven and successful, can dramatically alter their valuation and growth trajectory. The Company's business strategy is to source and develop breakthrough technologies and commercially attractive discoveries in the health, medtech and life science sectors worldwide. It targets technologies and discoveries using an extensive network of scientific, industry and academic contacts including scientists and key opinion leaders. Its investments include Fixit Medical, GEM Energia Limited and other investments. Its other investments include Oscillate Plc and Excalibur Medicines Ltd.
Directors
- Last Annual
- Last Interim
- Incorporated
- October 16th, 2007
- Public Since
- March 5th, 2008
- No. of Employees
- 3
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
Aquis Stock Exchange- Shares in Issue
- 2,310,106,271
- Address
- Kings Court, Railway Street, LONDON, EC2A 2EW
- Web
- https://igraineplc.com/
- Phone
- +44 2078871401
- Auditors
- Edwards Veeder LLP
Latest News for ETHY
Upcoming Events for ETHY
Similar to ETHY
Adsure Services
Aquis Stock Exchange
Asia Wealth group
Aquis Stock Exchange
B Hodl
Aquis Stock Exchange
BWA
Aquis Stock Exchange
Capital for Colleagues
Aquis Stock Exchange
FAQ
As of Today at 01:32 UTC, shares in EthTry are trading at 0.17p. This share price information is delayed by 15 minutes.
Shares in EthTry last closed at 0.17p and the price had moved by -40% over the past 365 days. In terms of relative price strength the EthTry share price has underperformed the FTSE All Share Index by -45.93% over the past year.
There is no consensus recommendation for this security.
Find out moreEthTry does not currently pay a dividend.
EthTry does not currently pay a dividend.
EthTry does not currently pay a dividend.
To buy shares in EthTry you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 0.17p, shares in EthTry had a market capitalisation of .
Here are the trading details for EthTry:
- Country of listing: United Kingdom
- Exchange: AQS
- Ticker Symbol: ETHY
Based on an overall assessment of its quality, value and momentum EthTry is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like EthTry. Over the past six months, its share price has underperformed the FTSE All Share Index by -31.9%.
As of the last closing price of 0.17p, shares in EthTry were trading -7.41% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The EthTry PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 0.17p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
EthTry's management team is headed by:
- David Levis - NED
- Oliver Murphy - EDR
- Patrick Chopard - CEO
- John Robinson - SEC
- Mike Murphy - FDR